Related Experiment Video
Updated: Dec 31, 2025

3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache
Published on: June 2, 2014
The Headache Pipeline: Excitement and Uncertainty
Alan M Rapoport1, Peter McAllister1
1Neurology, New England Institute for Neurology and Headache, Stamford, CT, USA.
New migraine treatments are emerging, including CGRP antagonists and neurostimulators. While safety and cost are considerations, this robust pipeline offers hope for patients seeking better headache relief.
Area of Science:
- Neurology
- Pharmacology
Background:
- The migraine treatment landscape is rapidly evolving with novel therapeutic options.
- Several calcitonin gene-related peptide (CGRP) antagonist monoclonal antibodies are approved, with more anticipated.
- Emerging small molecule CGRP receptor antagonists offer new avenues for acute and preventive migraine care.
Related Concept Videos
Analgesia and Pain Management
The Availability Heuristic
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
Two synthetic agonists of THC,...
Frustration and Conflict: Approach-Approach, Approach-Avoidance
One common type of conflict is the Approach–Approach Conflict. In this case, a person faces two desirable...
Frustration and Conflict: Avoidance-Avoidance, Double-Approach Avoidance

